tert-butyl 3-(difluoromethyl)-3-hydroxyazetidine-1-carboxylate

Catalog No. :
ACJNXR975
CAS No. :
1540342-18-4
Molecular Formula :
C9H15F2NO3
Molecular Weight :
223.22

IUPAC Name:tert-butyl 3-(difluoromethyl)-3-hydroxyazetidine-1-carboxylate

tert-butyl 3-(difluoromethyl)-3-hydroxyazetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$567.00Login to see priceInquiryInquiry
100mg95%$840.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 3-(difluoromethyl)-3-hydroxyazetidine-1-carboxylate
IUPAC Nametert-butyl 3-(difluoromethyl)-3-hydroxyazetidine-1-carboxylate
MDL No.MFCD23943579
Molecular FormulaC9H15F2NO3
Molecular Weight223.22
SMILESO=C(N1CC(O)(C(F)F)C1)OC(C)(C)C
InChI KeyLHZIXUHLIZYFAA-UHFFFAOYSA-N
Synonymtert-butyl3-(difluoromethyl)-3-hydroxyazetidine-1-carboxylate(WXFC0401);tert-butyl3-(difluoromethyl)-3-hydroxyazetidine-1-carboxylate;1-Azetidinecarboxylic acid, 3-(difluoromethyl)-3-hydroxy-, 1,1-dimethylethyl ester
CAS No.1540342-18-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJNXR975 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJNXR975 route product structure diagram
    ACJNXR9751540342-18-4
Inquiry

2. ACJNXR975 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJNXR975 route product structure diagram
    ACJNXR9751540342-18-4
Inquiry

Comments (0)